According to Taisho Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.26 B. In 2022 the company made a revenue of $2.22 B a decrease over the years 2021 revenue that were of $2.39 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.26 B | 2.13% |
2022 | $2.22 B | -7.12% |
2021 | $2.39 B | -12.87% |
2020 | $2.74 B | 9.67% |
2019 | $2.50 B | 4.26% |
2018 | $2.40 B | -3.23% |
2017 | $2.48 B | -4.96% |
2016 | $2.61 B | 7.47% |
2015 | $2.42 B | -9.19% |
2014 | $2.67 B | -9.27% |
2013 | $2.94 B | -14.1% |
2012 | $3.43 B | -0.22% |
2011 | $3.44 B | 12.47% |
2010 | $3.05 B | 11.07% |
2009 | $2.75 B |